C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/00 (2006.01) C12Q 1/02 (2006.01)
Patent
CA 2557677
Methods for predicting patient tolerability to therapeutic agents, such as cytokines, lymphokines and immunotoxins, are disclosed. The methods utilize an in vitro model of vascular leak syndrome (VLS) to assess the effect of the agent in question on the permeability of large proteins across confluent monolayers of endothelial cells (EC).
L'invention concerne des méthodes permettant de prédire la tolérabilité d'agents thérapeutiques, tels que des cytokines, des lymphokines et des immunotoxines, chez des patients. Ces méthodes se fondent sur un modèle in vitro du syndrome de fuite vasculaire (VLS) pour évaluer les effets de l'agent en question sur la perméabilité de grosses protéines à travers des monocouches confluentes de cellules endothéliales (EC).
Cao Ying
Denis-Mize Kimberly
Wilson Susan E.
Borden Ladner Gervais Llp
Chiron Corporation
Novartis Vaccines And Diagnostics Inc.
LandOfFree
In vitro test system for predicting patient tolerability of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with In vitro test system for predicting patient tolerability of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and In vitro test system for predicting patient tolerability of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1605089